upgrade to Tier 1 to access blurred content, display up to 300 records, and unlimited CSV download
Data last updated 2025-02-04 06:46:14 -0600 US CDT
Insider Sentiment
| Company Name | Sector | Industry | Shares Outstanding(Mil) | 52-week High/Low | Period | Acq/Dsp Transaction Countb | Ids/Sec/Mkt Quantc | Acq/Dsp Shares Amountb | Acq/Dsp PctSOd |
|---|---|---|---|---|---|---|---|---|---|
| Castle Biosciences Inc | Health Care | Medical Specialty Equipment/Services | 28.01 |
17.0
35.8
28.2
|
3-month |
0 / 44
|
|
0 / 80882
|
0.0 / 0.3 |
| 6-month |
0 / 129
|
|
0 / 159857
|
0.0 / 0.6 |
Data last updated 2025-02-01 06:40:01 -0600 US CDT
Major Shareholders
| Shareholder | Relation | Report Date | Holding Pct | Sharesa | Shares(Previous Report Date)a | Transactions (3 month)b | Transactions (6 month)b |
|---|---|---|---|---|---|---|---|
| Mgc Venture Partners 2013 Gp, Llc | 10% Owner | 2020-05-19 | 6.1% | 1714020 (-1.2%, NA%) | 1735936 (2020-05-14) | ||
| Sofinnova Healthquest Partners, L.P. | See Remarks | 2020-05-19 | 5.1% | 1433577 (0.0%, NA%) | 1433577 (2020-05-14) | ||
| Cook Joseph C. Iii | Director | 2021-03-22 | 2.7% | 753534 (1.6%, NA%) | 741305 (2020-12-18) | ||
| Kabakoff David S | Director | 2021-06-21 | 1.8% | 503577 (-5.5%, NA%) | 533577 (2021-04-07) | ||
| Maetzold Derek J | Pres. & Chief Exec. Officer | 2025-01-15 | 1.4% | 381894 (-0.6%, -5.6%) | 384459 (2025-01-08) |
C: 0 / 43
S: 0 / 61122 P: NA / 29.75 |
C: 0 / 106
S: 0 / 91047 P: NA / 29.99 |
| Oelschlager Kristen M | Chief Operating Officer | 2024-12-11 | 0.5% | 152522 (13.1%, 13.1%) | 134841 (2024-09-05) |
C: 0 / 1
S: 0 / 5832 P: NA / 29.21 |
|
| Juvenal Tobin W | Chief Commercial Officer | 2025-01-08 | 0.3% | 72173 (-2.9%, 27.9%) | 74403 (2024-12-11) |
C: 0 / 2
S: 0 / 5737 P: NA / 33.4 |
C: 0 / 3
S: 0 / 8837 P: NA / 34.1 |
| Aspinall Mara G. | Director | 2024-06-04 | 0.2% | 44139 (24.3%, NA%) | 35503 (2023-06-06) | ||
| Stokes Frank | Chief Financial Officer | 2024-12-11 | 0.2% | 43365 (40.7%, 14.9%) | 30823 (2024-11-19) |
C: 0 / 1
S: 0 / 6923 P: NA / 29.93 |
C: 0 / 2
S: 0 / 16923 P: NA / 27.43 |
| Monzon Federico A. | Chief Medical Officer | 2020-05-26 | 0.1% | 31459 (201.1%, NA%) | 10449 (2019-07-24) | ||
| Bradbury Daniel | Director | 2025-01-08 | 0.1% | 21158 (-27.0%, -42.5%) | 29025 (2024-12-05) |
C: 0 / 6
S: 0 / 15734 P: NA / 30.06 |
C: 0 / 18
S: 0 / 47218 P: NA / 29.99 |
| Goldberg Ellen | Director | 2024-07-16 | 0.1% | 18581 (2.4%, NA%) | 18141 (2024-05-29) | ||
| Olson Tiffany | Director | 2024-07-03 | 0.1% | 17233 (5.1%, NA%) | 16403 (2024-05-29) | ||
| Caple Kim | Director | 2024-07-16 | 0.0% | 13781 (3.3%, NA%) | 13341 (2024-05-29) | ||
| Harrison Miles | Director | 2024-05-29 | 0.0% | 13291 (185.5%, NA%) | 4655 (2023-06-06) |
a Total of direct and indirect accounts with percentage change comparing with (previous report, 3 months ago). The latter is NA when no change was found in the last 3 months.
Notice: Shares amount and percentage change 1) do not reflect intraday conversion and execution of derivative securities. 2) may subject to correction on amendment filing.
b Vital&Spontaneous transactions of the past 3 and 6 months, respectively. For acquisitions, code P (open market purchase), L (small acquisition), and I (at discretion of broker) are counted. For dispositions, code S (open market sell), D (sell back to issuer) and I (at discretion of broker) are counted. "C:" count of number of transactions. "S:" shares amount involved in corrresponding transactions. "P:" average per share price of the transactions (for reference only). Horizontal bar chart denotes shares amount of acquisitions and dispositions. Black thin bar is fixed size ruler for easy comparison between reporters.
c Quantile value of transaction count in b among industry peers, sector peers, and the market, respectively.
d Percentage of transaction shares amount to shares outstanding.
Notice: red exclamation mark (!) represents the reporter has Form 4 amendment filings in the latest three reports.
Non-derivative Transactions Chart
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records
what is this?
Non-derivative Transactions Table
CSV download
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records what is this?
|
|
|
Tips: type "code_p" to show transactions with code "P".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-15 | 2025-01-13 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 150.0 | 2.85 | 0.05 | 28.03 | By The Maetzold 2018 Remainder Trust Fbo Emily Carol Kirk | Common Stock | CASTLE BIOSCIENCES INC | code S | 5110.0
|
28.01 (CSTL) |
| 2025-01-15 | 2025-01-13 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 150.0 | 2.85 | 0.05 | 28.03 | By The Maetzold 2018 Remainder Trust Fbo Peter Douglas Maetzold | Common Stock | CASTLE BIOSCIENCES INC | code S | 5104.0
|
28.01 (CSTL) |
| 2025-01-15 | 2025-01-13 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 150.0 | 2.85 | 0.05 | 28.03 | By The Maetzold 2018 Remainder Trust Fbo Hannah Elizabeth Maetzold | Common Stock | CASTLE BIOSCIENCES INC | code S | 5104.0
|
28.01 (CSTL) |
| 2025-01-15 | 2025-01-13 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 505.0 | 0.71 | 0.18 | 28.03 | By The Maetzold Descendants 2020 Trust | Common Stock | CASTLE BIOSCIENCES INC | code S | 71081.0
|
28.01 (CSTL) |
| 2025-01-15 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 122866.0 | 0 | 43.87 | 0.0 | By Djm Grantor Retained Annuity Trust No. 5 | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2025-01-15 | 2025-01-13 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 150.0 | 2.85 | 0.05 | 28.03 | By The Maetzold 2018 Remainder Trust Fbo John Derek Maetzold | Common Stock | CASTLE BIOSCIENCES INC | code S | 5104.0
|
28.01 (CSTL) |
| 2025-01-15 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 26134.0 | 0 | 9.33 | 0.0 | By Djm Grantor Retained Annuity Trust No. 6 | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2025-01-15 | 2025-01-13 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 474.0 | 0.78 | 0.17 | 28.03 | By Derek Maetzold 2020 Irrevocable Trust | Common Stock | CASTLE BIOSCIENCES INC | code S | 60573.0
|
28.01 (CSTL) |
| 2025-01-15 | 2025-01-13 | 2025-01-13 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 986.0 | 1.21 | 0.35 | 28.03 | Direct | Common Stock | CASTLE BIOSCIENCES INC | code S | 80818.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 2025-01-06 to 2025-01-07 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 2958.0 | 3.49 | 1.06 | 29.66 | Direct | Common Stock | CASTLE BIOSCIENCES INC | code S | 81804.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 2025-01-06 to 2025-01-07 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 1422.0 | 2.28 | 0.51 | 29.66 | By Derek Maetzold 2020 Irrevocable Trust | Common Stock | CASTLE BIOSCIENCES INC | code S | 61047.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 26134.0 | 0 | 9.33 | 0.0 | By Djm Grantor Retained Annuity Trust No. 6 | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2025-01-08 | 2025-01-06 | 2025-01-06 to 2025-01-07 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 450.0 | 7.88 | 0.16 | 29.66 | By The Maetzold 2018 Remainder Trust Fbo Emily Carol Kirk | Common Stock | CASTLE BIOSCIENCES INC | code S | 5260.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 2025-01-06 to 2025-01-07 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 448.0 | 7.86 | 0.16 | 29.66 | By The Maetzold 2018 Remainder Trust Fbo Hannah Elizabeth Maetzold | Common Stock | CASTLE BIOSCIENCES INC | code S | 5254.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 122866.0 | 0 | 43.87 | 0.0 | By Djm Grantor Retained Annuity Trust No. 5 | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2025-01-08 | 2025-01-06 | 2025-01-06 to 2025-01-07 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 1515.0 | 2.07 | 0.54 | 29.66 | By The Maetzold Descendants 2020 Trust | Common Stock | CASTLE BIOSCIENCES INC | code S | 71586.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 2025-01-06 to 2025-01-07 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 448.0 | 7.86 | 0.16 | 29.66 | By The Maetzold 2018 Remainder Trust Fbo Peter Douglas Maetzold | Common Stock | CASTLE BIOSCIENCES INC | code S | 5254.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 2025-01-06 to 2025-01-07 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 448.0 | 7.86 | 0.16 | 29.66 | By The Maetzold 2018 Remainder Trust Fbo John Derek Maetzold | Common Stock | CASTLE BIOSCIENCES INC | code S | 5254.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 4 | Bradbury Daniel | DIRECTOR | holding | 13291.0 | 0 | 4.75 | 0.0 | Direct | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2025-01-08 | 2025-01-06 | 2025-01-06 | 4 | Bradbury Daniel | DIRECTOR | dsp | 1425.0 | 50.0 | 0.51 | 29.14 | By Daniel Bradbury Irrevocable Descendant's Trust | Common Stock | CASTLE BIOSCIENCES INC | code S | 1425.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 2025-01-06 | 4 | Bradbury Daniel | DIRECTOR | dsp | 1425.0 | 50.0 | 0.51 | 29.14 | By Annette Bradbury Irrevocable Descendant's Trust | Common Stock | CASTLE BIOSCIENCES INC | code S | 1425.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 2025-01-06 | 4 | Bradbury Daniel | DIRECTOR | dsp | 5017.0 | 50.0 | 1.79 | 29.14 | By Llc | Common Stock | CASTLE BIOSCIENCES INC | code S | 5017.0
|
28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 2025-01-06 | 4 | Juvenal Tobin W | CHIEF COMMERCIAL OFFICER | dsp | 2230.0 | 3.09 | 0.8 | 30.0 | Direct | Common Stock | CASTLE BIOSCIENCES INC | code S | 69943.0 | 28.01 (CSTL) |
| 2025-01-08 | 2025-01-06 | 4 | Juvenal Tobin W | CHIEF COMMERCIAL OFFICER | holding | 2230.0 | 0 | 0.8 | 0.0 | By Tobin W And Susan M Juvenal Family Revocable Trust | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2024-12-19 | 2024-12-17 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 5710.0 | 0 | 2.04 | 0.0 | By The Maetzold 2018 Remainder Trust Fbo Emily Carol Kirk | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2024-12-19 | 2024-12-17 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 5702.0 | 0 | 2.04 | 0.0 | By The Maetzold 2018 Remainder Trust Fbo Peter Douglas Maetzold | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2024-12-19 | 2024-12-17 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 5702.0 | 0 | 2.04 | 0.0 | By The Maetzold 2018 Remainder Trust Fbo John Derek Maetzold | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2024-12-19 | 2024-12-17 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 26134.0 | 0 | 9.33 | 0.0 | By Djm Grantor Retained Annuity Trust No. 6 | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2024-12-19 | 2024-12-17 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 62469.0 | 0 | 22.3 | 0.0 | By Derek Maetzold 2020 Irrevocable Trust | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) | ||
| 2024-12-19 | 2024-12-17 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | holding | 5702.0 | 0 | 2.04 | 0.0 | By The Maetzold 2018 Remainder Trust Fbo Hannah Elizabeth Maetzold | Common Stock | CASTLE BIOSCIENCES INC | NA | 28.01 (CSTL) |
Derivative Transactions Chart
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records
what is this?
Derivative Transactions Table
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records what is this?
|
|
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-11 | 2024-12-09 | 2024-12-09 to 2024-12-10 | 4 | Juvenal Tobin W | CHIEF COMMERCIAL OFFICER | dsp | 23880.0 | 79.47 | 8.53 | 0.0 | Direct | Restricted Stock Units | CASTLE BIOSCIENCES INC | code M | 6170.0
|
28.01 (CSTL) |
| 2024-12-11 | 2024-12-09 | 2024-12-09 to 2024-12-10 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | dsp | 54283.0 | 77.87 | 19.38 | 0.0 | Direct | Restricted Stock Units | CASTLE BIOSCIENCES INC | code M | 15424.0
|
28.01 (CSTL) |
| 2024-12-11 | 2024-12-09 | 2024-12-09 to 2024-12-10 | 4 | Stokes Frank | CHIEF FINANCIAL OFFICER | dsp | 22786.0 | 78.69 | 8.14 | 0.0 | Direct | Restricted Stock Units | CASTLE BIOSCIENCES INC | code M | 6170.0
|
28.01 (CSTL) |
| 2024-12-11 | 2024-12-09 | 2024-12-09 to 2024-12-10 | 4 | Oelschlager Kristen M | CHIEF OPERATING OFFICER | dsp | 23880.0 | 79.47 | 8.53 | 0.0 | Direct | Restricted Stock Units | CASTLE BIOSCIENCES INC | code M | 6170.0
|
28.01 (CSTL) |
| 2024-11-07 | 2024-11-05 | 2024-11-05 | 4 | Juvenal Tobin W | CHIEF COMMERCIAL OFFICER | dsp | 3507.0 | 17.44 | 1.25 | 3.38 | Direct | Stock Option (Right To Buy) | CASTLE BIOSCIENCES INC | code M | 16603.0 | 28.01 (CSTL) |
| 2024-11-05 | 2024-11-01 | 2024-11-01 | 4 | Juvenal Tobin W | CHIEF COMMERCIAL OFFICER | dsp | 1100.0 | 5.19 | 0.39 | 3.38 | Direct | Stock Option (Right To Buy) | CASTLE BIOSCIENCES INC | code M | 20110.0 | 28.01 (CSTL) |
| 2024-08-13 | 2024-08-09 | 2024-08-09 | 4 | Stokes Frank | CHIEF FINANCIAL OFFICER | acq | 9744.0 | 100.0 | 3.51 | 0.0 | Direct | Performance Based Stock Unit | CASTLE BIOSCIENCES INC | code A | 9744.0 | 27.74 (CSTL) |
| 2024-08-13 | 2024-08-09 | 2024-08-09 | 4 | Maetzold Derek J | PRES. & CHIEF EXEC. OFFICER | acq | 66991.0 | 100.0 | 24.15 | 0.0 | Direct | Performance Based Stock Unit | CASTLE BIOSCIENCES INC | code A | 66991.0 | 27.74 (CSTL) |
| 2024-08-13 | 2024-08-09 | 2024-08-09 | 4 | Juvenal Tobin W | CHIEF COMMERCIAL OFFICER | acq | 10641.0 | 100.0 | 3.84 | 0.0 | Direct | Performance Based Stock Unit | CASTLE BIOSCIENCES INC | code A | 10641.0 | 27.74 (CSTL) |
| 2024-08-13 | 2024-08-09 | 2024-08-09 | 4 | Oelschlager Kristen M | CHIEF OPERATING OFFICER | acq | 10640.0 | 100.0 | 3.84 | 0.0 | Direct | Performance Based Stock Unit | CASTLE BIOSCIENCES INC | code A | 10640.0 | 27.74 (CSTL) |
Form 3 CSV download
| Filing Date | Date requiring statement | Form Type | Reporter | Relation | Amounta | ‱(SO)c | Avg Excercisable Prcd | Account | Type | Full Name | Shares Outstanding (Million)e |
|---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to 30 records per table for current tier. (Access Guide)